Characterization of immune responses to cardiac self-antigens myosin and vimentin in human cardiac allograft recipients with antibody-mediated rejection and cardiac allograft vasculopathy - sprookjes - yvandenbroek - TriplyDB

Characterization of immune responses to cardiac self-antigens myosin and vimentin in human cardiac allograft recipients with antibody-mediated rejection and cardiac allograft vasculopathy

Characterization of immune responses to cardiac self-antigens myosin and vimentin in human cardiac allograft recipients with antibody-mediated rejection and cardiac allograft vasculopathy

http://www.wikidata.org/entity/Q34238488

about

An important role for autoimmunity in the immunopathogenesis of chronic allograft rejection Significance of T helper 17 immunity in transplantation Antibodies reactive to non-HLA antigens in transplant glomerulopathy Anticardiac myosin immunity and chronic allograft vasculopathy in heart transplant recipients.Vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritis Autoimmune sensitization to cardiac myosin leads to acute rejection of cardiac allografts in miniature swine Antibody-mediated rejection: an evolving entity in heart transplantation.Incidence and early outcomes associated with pre-transplant antivimentin antibodies in the cardiac transplantation population.Generation of Antigen Microarrays to Screen for Autoantibodies in Heart Failure and Heart Transplantation The Pathogenesis and Therapeutic Implications of Tubulointerstitial Inflammation in Human Lupus Nephritis Bronchiolitis obliterans syndrome: the Achilles' heel of lung transplantation.Inflammatory signalling associated with brain dead organ donation: from brain injury to brain stem death and posttransplant ischaemia reperfusion injury.Immune response to extracellular matrix collagen in chronic hepatitis C-induced liver fibrosis.A role for antibodies to human leukocyte antigens, collagen-V, and K-α1-Tubulin in antibody-mediated rejection and cardiac allograft vasculopathy.Analysis of the Influence of HLA-A Matching Relative to HLA-B and -DR Matching on Heart Transplant Outcomes.Mechanisms of chronic cardiac allograft rejection Role of anti-vimentin antibodies in allograft rejection.Immunologic monitoring in transplantation revisited.Role of antibodies to self-antigens in chronic allograft rejection: potential mechanism and therapeutic implications.Chronic rejection: a significant role for Th17-mediated autoimmune responses to self-antigens.Immune responses to self-antigens (autoimmunity) in allograft rejection.Interplay between immune responses to HLA and non-HLA self-antigens in allograft rejection.Moving beyond HLA: a review of nHLA antibodies in organ transplantation.Transplant glomerulopathy: the interaction of HLA antibodies and endothelium New answers to old conundrums: what antibodies, exosomes and inflammasomes bring to the conversation. Canadian National Transplant Research Program international summit report.Advances in Pretransplant Donor-Specific Antibody Testing in Solid Organ Transplantation: From Bench to Bedside.Overview of pathophysiology and treatment of human lupus nephritis.Immune Responses to Tissue-Restricted Nonmajor Histocompatibility Complex Antigens in Allograft Rejection Impact of Non-Human Leukocyte Antigen-Specific Antibodies in Kidney and Heart Transplantation.Role of alloimmunity and autoimmunity in allograft rejection.Detection of antibodies to self-antigens (K-alpha 1 tubulin, collagen I, II, IV, and V, myosin, and vimentin) by enzyme-linked immunosorbent assay (ELISA).Lung-Restricted Antibodies Mediate Primary Graft Dysfunction and Prevent Allotolerance after Murine Lung Transplantation.Antibodies in transplantation: the effects of HLA and non-HLA antibody binding and mechanisms of injury.Acute pump failure of the transplanted heart: diagnostic and therapeutic challenges.Cardiac allograft vasculopathy: a complex multifactorial sequela of heart transplantation.Autoimmune Reactivity in Graft Injury: Player or Bystander?Evolving concepts and treatment strategies for cardiac allograft vasculopathy.Higher risk of kidney graft failure in the presence of anti-angiotensin II type-1 receptor antibodies.Exosomes Expressing the Self-Antigens Myosin and Vimentin Play an Important Role in Syngeneic Cardiac Transplant Rejection Induced by Antibodies to Cardiac Myosin.A survey of current practice for antibody-mediated rejection in heart transplantation.

P2860

Q26827623-86FA5E68-CB21-427E-B317-E71C2AA43874 Q26998887-7D743859-C633-4F88-9232-E6E01B606695 Q35012455-B3172AF2-C0FD-4AFA-98CC-66536F444291 Q35091339-6AA67096-5981-495D-A6EE-841D1EDF2A42 Q35324023-CA32656B-BCD0-44CB-8151-48417C73BB65 Q35596433-D9657452-0EA4-4DC7-80F7-607EF60F3D32 Q35876250-AB9DC79E-34C0-4A39-93BC-6718A0E36CD0 Q35883267-C6D33A72-9887-45F8-BCA8-7F5B01E065D1 Q35954030-273B493A-F74F-4C61-A61C-B11E46519C58 Q36299959-E109E520-ACCD-443E-B244-1D565D4386C3 Q36623201-AE5DFEC6-58BA-475B-814C-11425FB5C61C Q36829834-867C0306-B6FC-4888-8AC6-D01433E2A07E Q36979114-EC6ABD2F-2D35-4AA2-A015-69B92F04DF3F Q37044200-0639C568-85F8-4584-A919-9E368589349F Q37097749-37565F2A-1D90-4464-9B24-5D92779E26D5 Q37197706-57DDA044-AFBB-4A78-8B84-A30B8F36D2A8 Q37286553-08389748-9DF6-4FF3-A751-2729616E09D7 Q37970214-0A58703E-40F4-44AF-A2E2-08E6612E9854 Q38025804-322C4041-0D48-4CDC-BB27-78DA54633D0D Q38053174-C84C8B1F-D6B4-4B28-A65E-0438FFE95DA3 Q38110566-3878EFFD-3657-4017-9217-64BDCE73A2F8 Q38123309-0A4C0119-4933-4686-84A2-B724D4DB8800 Q38123310-F213BFE6-BED2-47B5-B705-17D16589929D Q38205229-FBC0FAF3-60DC-4673-9934-E6CAD2FF54EF Q38668025-889E0751-276C-4C31-9060-3B9B6ACEFF8E Q38818993-72798BE0-E179-4EB3-8D85-061EFA2DA007 Q38876110-56B76C85-6CA6-44D9-88AE-2774470BFC29 Q39121365-94473F1F-4364-461D-8472-2D335081CD73 Q39268286-41A464BE-C63F-44AF-B9B9-E4735B0F1CAD Q41226453-14660BDD-61E3-47CF-B513-6B1377CD9520 Q41226640-745F7E9D-3BAD-4C71-8BA7-ED0712C85ED3 Q41631328-4DE04B13-E3EA-4A33-9DB5-288BD9A63515 Q41849097-603F4669-4E2A-46C3-9AAA-2BED24ADD076 Q42840060-C84D44AC-9162-417C-B028-C09B2272887A Q42968537-39B737A9-B38C-40CA-A845-D819432F5841 Q45763669-A3900B41-F4EA-414D-AC85-81CD24233752 Q47613394-945D2CEE-5EA0-4083-BB70-8CED5E52701A Q47789001-95CCD0B1-4FEB-4893-90C8-9915BBCF4EC5 Q50117728-46757961-EC99-4A58-98B8-591104F36E0B Q51256229-1C1CBB43-4331-4802-B272-475C4A34A22E

P2860

Characterization of immune responses to cardiac self-antigens myosin and vimentin in human cardiac allograft recipients with antibody-mediated rejection and cardiac allograft vasculopathy

http://www.wikidata.org/entity/Q34238488

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Characterization of immune res ...... cardiac allograft vasculopathy

@ast

Characterization of immune res ...... cardiac allograft vasculopathy

@en

Characterization of immune res ...... cardiac allograft vasculopathy

@nl

type

label

Characterization of immune res ...... cardiac allograft vasculopathy

@ast

Characterization of immune res ...... cardiac allograft vasculopathy

@en

Characterization of immune res ...... cardiac allograft vasculopathy

@nl

prefLabel

Characterization of immune res ...... cardiac allograft vasculopathy

@ast

Characterization of immune res ...... cardiac allograft vasculopathy

@en

Characterization of immune res ...... cardiac allograft vasculopathy

@nl

P1433

Q34238488-F8329D1F-4448-4394-9366-D9D74FD92E22

P1476

Q34238488-BF8B4941-E47E-4C1E-AF89-9B6AB9BCFFE8

P2093

Q34238488-262E8A6E-FA5B-42D4-A585-1A91A8892F72

Q34238488-6E417D9D-0D75-489C-BFAC-DBEC65090B3F

Q34238488-6F2D0E56-1A15-40D0-B649-FCBD765FC3FF

Q34238488-7944AF8A-94DA-4BED-839A-A79CFF7B59EA

Q34238488-D7847890-5BC4-44F9-8914-3508482C5913

Q34238488-D8CEEE0A-4C2D-4599-983F-1B00CD60FEC9

Q34238488-F3AB413B-C247-4FF8-BC52-BB56B16121F2

Q34238488-F8729DEF-BF54-42EA-8463-136C09F1A5E3

P2860

Q34238488-01BDAA6B-74C9-4AEF-9030-55DA942BFF65

Q34238488-09D661DB-E194-4ED2-8308-886A715E0D6C

Q34238488-1062C8C8-388C-4247-A8AD-34D7DE4EDFEC

Q34238488-17BDDDE8-298C-4EB0-B50A-6EC32249380F

Q34238488-27A6EA1F-FF2B-46F4-8546-59347BAF7FA3

Q34238488-291D1143-EDC5-491C-ADC6-DD488B7155DC

Q34238488-31142C8B-C5A7-416D-BCDE-85AD75769771

Q34238488-371D2924-4CBF-437E-AAB2-84A6828312BE

Q34238488-39019086-6806-4CFA-AB38-C95238C8D354

Q34238488-3AE8C8C3-E223-4F44-8A05-CA12B89C1505

P304

Q34238488-A97722E3-5145-400B-9F01-CD3D9FAE1E33

P31

Q34238488-FDA06395-861C-4F03-869B-BDF27A481050

P356

Q34238488-AB72B230-2005-41C6-9E22-00F6F5BDDED1

P433

Q34238488-889891AA-3206-4041-832F-E7E3F176DCA4

P478

Q34238488-47275DC9-85BA-4B03-AD77-FA394DA2ACA9

P577

Q34238488-40C3177F-5EB3-44D7-A9B0-74ED4BA84BE1

P5875

Q34238488-E25DBF21-2140-4E54-857F-CC900F980A39

P698

Q34238488-57B532CD-DC3E-4E37-8DAF-640E82762BC7

P921

Q34238488-F78145D4-544D-4377-9F53-FEE4B87DAFAC

P932

Q34238488-8C6436AA-6238-4F63-9137-B36CC8F69D2B

P356

J.HEALUN.2010.05.025

P1433

The Journal of Heart and Lung Transplantation

P1476

Characterization of immune res ...... cardiac allograft vasculopathy

@en

P2093

Chiraag Alur

http://www.w3.org/2001/XMLSchema#string

Dilip S Nath

http://www.w3.org/2001/XMLSchema#string

Donna Phelan

http://www.w3.org/2001/XMLSchema#string

Gregory A Ewald

http://www.w3.org/2001/XMLSchema#string

Haseeb Ilias Basha

http://www.w3.org/2001/XMLSchema#string

Nader Moazami

http://www.w3.org/2001/XMLSchema#string

Thalachallour Mohanakumar

http://www.w3.org/2001/XMLSchema#string

Venkataswarup Tiriveedhi

http://www.w3.org/2001/XMLSchema#string

P2860

IL-17: prototype member of an emerging cytokine family

Regulation of interferon-gamma during innate and adaptive immune responses

Interleukin-17 family members and inflammation

Screening of a HUVEC cDNA library with transplant-associated coronary artery disease sera identifies RPL7 as a candidate autoantigen associated with this disease.

De novo production of K-alpha1 tubulin-specific antibodies: role in chronic lung allograft rejection.

Transfer of tolerance to collagen type V suppresses T-helper-cell-17 lymphocyte-mediated acute lung transplant rejection

Increased erythrocyte C4D is associated with known alloantibody and autoantibody markers of antibody-mediated rejection in human lung transplant recipients.

Evidence for immune responses to a self-antigen in lung transplantation: role of type V collagen-specific T cells in the pathogenesis of lung allograft rejection.

Type V collagen-induced oral tolerance plus low-dose cyclosporine prevents rejection of MHC class I and II incompatible lung allografts.

Critical role of effector macrophages in mediating CD4-dependent alloimmune injury of transplanted liver parenchymal cells

P304

1277-1285

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.HEALUN.2010.05.025

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2010-07-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45113268

http://www.w3.org/2001/XMLSchema#string

P698

20615726

http://www.w3.org/2001/XMLSchema#string

P921

P932

2963681

http://www.w3.org/2001/XMLSchema#string